We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Immunodiagnostic Systems Holdings Plc | LSE:IDH | London | Ordinary Share | GB00B01YZ052 | ORD 2P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 378.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From May 2019 to May 2024
TIDMIDH
RNS Number : 8963C
Immunodiagnostic Systems Hldgs PLC
30 June 2016
Immunodiagnostic Systems Holdings plc
Director Dealing
30 June 2016
Immunodiagnostic Systems Holdings plc (IDH.L) ("IDS" or the "Company"), a specialist producer of manual and automated specialist diagnostic testing kits and instrumentation for the clinical and research markets, was advised on 30 June, that on 29 and 30 June, Peter Kaspar, Non-Executive Director, acquired 6,000 ordinary shares of 2p each ("Ordinary Shares") in the Company at an average price of 136.5p per Ordinary Share.
Following these purchases, Dr Kaspar is interested in 6,000 Ordinary Shares, 0.02% of the issued share capital of the Company.
For further information:
Hot Features
Premium
Immunodiagnostic Systems Tel : +44 (0)191
Holdings plc 519 0660
Patricio Lacalle, Chief
Executive Officer
Paul Martin, Group Finance
Director
Peel Hunt LLP Tel : +44 (0)207
418 8900
James Steel
Oliver Jackson
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHBRGDLSBXBGLG
(END) Dow Jones Newswires
June 30, 2016 13:15 ET (17:15 GMT)
1 Year Immunodiagnostic Systems Chart |
1 Month Immunodiagnostic Systems Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
